Sign inJoin waitlistJoin the waitlist

Raymond Thertulien

Physician · Presbyterian Hospital

Credentials: · · · · ·

History

Presbyterian Hospital
2022–Present

Hematology and Medical Oncology
Memorial Sloan Kettering Cancer Center
1998–2001
New York Presbyterian Hospital
1994–1997
University
Univ of Rochester Sch of Med & Dent
1990–1994
Brooklyn College, City University of New York
1986–1990

Research

Thalidomide and hematopoietic-cell transplantation for multiple myeloma
New England Journal of Medicine · 2006 · 583 citations
Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation
British Journal of Haematology · 2004 · 181 citations
Thalidomide and deep vein thrombosis in multiple myeloma: risk factors and effect on survival
Clinical Lymphoma · 2003 · 93 citations

BB
Bart Barlogie
11 papers
EA
Elias Anaissie
9 papers
Frits van Rhee
9 papers
Guido Tricot
9 papers
Maurizio Zangari
9 papers
CL
Choon-Kee Lee
5 papers
Giampaolo Talamo
5 papers
FM
Firas Muwalla
4 papers
Ashraf Badros
3 papers
KH
Klaus Hollmig
3 papers
Peter Voorhees
3 papers
Ajai Chari
2 papers

Clinical trials

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Site PI · Recruiting · Phase 3
GlaxoSmithKline
2024–2031
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2024–2030